Literature DB >> 17261632

Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia.

Vânia Lúcia Ribeiro da Matta1, Márcia de Souza Carvalho Melhem, Arnaldo Lopes Colombo, Maria Luiza Moretti, Laura Rodero, Gisele Madeira Duboc de Almeida, Marilena dos Anjos Martins, Silvia Figueiredo Costa, Maria Beatriz G Souza Dias, Márcio Nucci, Anna S Levin.   

Abstract

In vitro susceptibility of 58 isolates of Pichia anomala to five antifungal drugs using two broth microdilution methods (CLSI and EUCAST) was analyzed. Low susceptibility to itraconazole was observed. Fluconazole, voriconazole, amphotericin B, and caspofungin showed good antifungal activity, although relatively high drug concentrations were necessary to inhibit the isolates.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17261632      PMCID： PMC1855522          DOI： 10.1128/AAC.01038-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  41 in total

1.  Hansenula anomala infection in a neonate.

Authors:  A R Wong; H Ibrahim; H Van Rostenberghe; Z Ishak; M J Radzi
Journal:  J Paediatr Child Health       Date:  2000-12       Impact factor: 1.954

2.  Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in Northern India.

Authors:  A Chakrabarti; K Singh; A Narang; S Singhi; R Batra; K L Rao; P Ray; S Gopalan; S Das; V Gupta; A K Gupta; S M Bose; M M McNeil
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.

Authors:  M A Pfaller; D J Diekema; J H Rex; A Espinel-Ingroff; E M Johnson; D Andes; V Chaturvedi; M A Ghannoum; F C Odds; M G Rinaldi; D J Sheehan; P Troke; T J Walsh; D W Warnock
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

4.  In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.

Authors:  F Barchiesi; A M Tortorano; L F Di Francesco; M Cogliati; G Scalise; M A Viviani
Journal:  J Antimicrob Chemother       Date:  1999-02       Impact factor: 5.790

5.  International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.

Authors:  M A Pfaller; D J Diekema; R N Jones; H S Sader; A C Fluit; R J Hollis; S A Messer
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

6.  Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital.

Authors:  R Luzzati; G Amalfitano; L Lazzarini; F Soldani; S Bellino; M Solbiati; M C Danzi; S Vento; G Todeschini; C Vivenza; E Concia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-08       Impact factor: 3.267

7.  Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media.

Authors:  M A Pfaller; S A Messer; A Houston; K Mills; A Bolmstrom; R N Jones
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

8.  Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

Authors:  Luis Ostrosky-Zeichner; John H Rex; Peter G Pappas; Richard J Hamill; Robert A Larsen; Harold W Horowitz; William G Powderly; Newton Hyslop; Carol A Kauffman; John Cleary; Julie E Mangino; Jeannette Lee
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

9.  Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001).

Authors:  F Marco; C Danés; M Almela; A Jurado; J Mensa; J Puig de la Bellacasa; M Espasa; J A Martínez; M T Jiménez de Anta
Journal:  Diagn Microbiol Infect Dis       Date:  2003-08       Impact factor: 2.803

10.  The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: antifungal susceptibility patterns of 261 non-albicans Candida isolates from blood.

Authors:  Anna Maria Tortorano; Anna Lisa Rigoni; Emanuela Biraghi; Anna Prigitano; Maria Anna Viviani
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790
View more
  6 in total

1.  In vitro susceptibility of a large collection of Candida Strains against fluconazole and voriconazole by using the CLSI disk diffusion assay.

Authors:  Ana Carolina Azevedo; Fernando César Bizerra; Daniel Arquimedes da Matta; Leila Paula de Almeida; Robert Rosas; Arnaldo Lopes Colombo
Journal:  Mycopathologia       Date:  2010-12-23       Impact factor: 2.574

Review 2.  Update on the genus Trichosporon.

Authors:  Thomas C Chagas-Neto; Guilherme M Chaves; Arnaldo L Colombo
Journal:  Mycopathologia       Date:  2008-06-21       Impact factor: 2.574

3.  Fungemia by Candida pelliculosa (Pichia anomala) in a neonatal intensive care unit: a possible clonal origin.

Authors:  Carolina Maria da Silva; Ana Maria Rabelo de Carvalho Parahym; Mariele Porto Carneiro Leão; Neiva Tinti de Oliveira; Rosemary de Jesus Machado Amorim; Rejane Pereira Neves
Journal:  Mycopathologia       Date:  2012-12-12       Impact factor: 2.574

4.  Pichia anomala (Candida pelliculosa) fungemia in a patient with sickle cell disease.

Authors:  Austin W Chan; Emily J Cartwright; Sujan C Reddy; Colleen S Kraft; Yun F Wang
Journal:  Mycopathologia       Date:  2013-07-25       Impact factor: 2.574

5.  In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

Authors:  D J Diekema; S A Messer; L B Boyken; R J Hollis; J Kroeger; S Tendolkar; M A Pfaller
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

6.  Wickerhamomyces anomalous: A Rare Cause of Fungemia Causing Febrile Neutropenia in Acute Lymphoblastic Leukemia.

Authors:  Vibha Mehta; Aroop Mohanty; Suneeta Meena; J S Rahul; Nath Uttam Kumar; Debranjani Chattopadhyay; Anamika Bakliwal; Ranjana Choudhary; Pratima Gupta
Journal:  Case Rep Infect Dis       Date:  2020-12-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.